Tilray’s Major Production Expansion: Inside the Cannabis Giant’s Strategic Growth Plan
February 10, 2025
Rhea-AI Impact
Rhea-AI Sentiment
Rhea-AI Summary
Tilray Brands (TLRY) has completed Phase I of its accelerated cannabis supply chain growth plan, with full planting at its Aphria One and Aphria Diamond facilities in Canada. Previously idled sections during COVID-19 are now operational, adding 60 metric tonnes to annual production capacity, bringing the total Canadian capacity to 210 metric tonnes.
The company operates eight cultivation and manufacturing facilities across Canada and Europe, with a current global cannabis cultivation capacity of 247 metric tonnes. Phase II includes planting at the outdoor Cayuga site this spring. First sales from Phase I harvests are expected in late Q4, with Phase II harvest beginning in October 2025.
Tilray’s facilities include operations in Leamington, Nanaimo, Foss, Cayuga, and Masson in Canada, plus facilities in Cantanhede, Portugal, and Neumünster, Germany, serving over 20 legal cannabis markets worldwide.
Tilray Brands (TLRY) ha completato la Fase I del suo piano accelerato di crescita della catena di approvvigionamento della cannabis, con la piantumazione completa presso le sue strutture Aphria One e Aphria Diamond in Canada. Sezioni precedentemente inattive durante il COVID-19 sono ora operative, aggiungendo 60 tonnellate metriche alla capacità produttiva annuale, portando la capacità totale canadese a 210 tonnellate metriche.
L’azienda gestisce otto strutture di coltivazione e produzione in Canada e Europa, con una attuale capacità globale di coltivazione della cannabis di 247 tonnellate metriche. La Fase II include la piantumazione presso il sito all’aperto di Cayuga questa primavera. Le prime vendite dai raccolti della Fase I sono attese per la fine del quarto trimestre, con il raccolto della Fase II che inizierà nell’ottobre 2025.
Le strutture di Tilray includono operazioni a Leamington, Nanaimo, Foss, Cayuga e Masson in Canada, oltre a strutture a Cantanhede, Portogallo, e Neumünster, Germania, servendo oltre 20 mercati legali della cannabis in tutto il mondo.
Tilray Brands (TLRY) ha completado la Fase I de su plan de crecimiento acelerado de la cadena de suministro de cannabis, con la siembra completa en sus instalaciones Aphria One y Aphria Diamond en Canadá. Las secciones previamente inactivas durante el COVID-19 ya están operativas, añadiendo 60 toneladas métricas a la capacidad de producción anual, llevando la capacidad total canadiense a 210 toneladas métricas.
La compañía opera ocho instalaciones de cultivo y manufactura en Canadá y Europa, con una capacidad global actual de cultivo de cannabis de 247 toneladas métricas. La Fase II incluye la siembra en el sitio al aire libre de Cayuga esta primavera. Se esperan las primeras ventas de las cosechas de la Fase I a finales del cuarto trimestre, con la cosecha de la Fase II comenzando en octubre de 2025.
Las instalaciones de Tilray incluyen operaciones en Leamington, Nanaimo, Foss, Cayuga y Masson en Canadá, además de instalaciones en Cantanhede, Portugal, y Neumünster, Alemania, sirviendo a más de 20 mercados legales de cannabis en todo el mundo.
Tilray Brands (TLRY)는 캐나다의 Aphria One 및 Aphria Diamond 시설에서 전면적인 식재를 진행하며 가속화된 대마 공급망 성장 계획의 1단계를 완료했습니다. COVID-19 동안 비활성 상태였던 구역이 현재 가동 중이며, 연간 생산 능력에 60 미터 톤을 추가하여 캐나다의 총 생산 능력을 210 미터 톤으로 증가시켰습니다.
회사는 캐나다와 유럽에 걸쳐 8개의 재배 및 제조 시설를 운영하고 있으며, 현재 전 세계 대마 재배 능력은 247 미터 톤입니다. 2단계는 이번 봄에 Cayuga 야외 사이트에서 식재하는 것을 포함합니다. 1단계 수확의 첫 판매는 4분기 말에 예상되며, 2단계 수확은 2025년 10월에 시작될 예정입니다.
Tilray의 시설에는 캐나다의 Leamington, Nanaimo, Foss, Cayuga, Masson에서의 운영과 더불어 포르투갈의 Cantanhede 및 독일의 Neumünster에 시설이 있어 전 세계 20개 이상의 합법적인 대마 시장에 서비스를 제공합니다.
Tilray Brands (TLRY) a complété la Phase I de son plan de croissance accélérée de la chaîne d’approvisionnement en cannabis, avec une plantation complète dans ses installations Aphria One et Aphria Diamond au Canada. Des sections auparavant inactives pendant la COVID-19 sont désormais opérationnelles, ajoutant 60 tonnes métriques à la capacité de production annuelle, portant la capacité totale canadienne à 210 tonnes métriques.
L’entreprise gère huit installations de culture et de fabrication à travers le Canada et l’Europe, avec une capacité actuelle de culture du cannabis de 247 tonnes métriques. La Phase II comprend la plantation sur le site extérieur de Cayuga ce printemps. Les premières ventes des récoltes de la Phase I sont attendues fin T4, avec les récoltes de la Phase II commençant en octobre 2025.
Les installations de Tilray comprennent des opérations à Leamington, Nanaimo, Foss, Cayuga et Masson au Canada, ainsi que des installations à Cantanhede, au Portugal, et à Neumünster, en Allemagne, desservant plus de 20 marchés légaux de cannabis à travers le monde.
Tilray Brands (TLRY) hat Phase I seines beschleunigten Wachstumsplans für die Cannabis-Lieferkette abgeschlossen, mit vollständiger Bepflanzung in seinen Anlagen Aphria One und Aphria Diamond in Kanada. Während COVID-19 stillgelegte Bereiche sind jetzt wieder in Betrieb, was der jährlichen Produktionskapazität 60 metrische Tonnen hinzufügt und die gesamte kanadische Kapazität auf 210 metrische Tonnen bringt.
Das Unternehmen betreibt acht Anbau- und Produktionsstätten in Kanada und Europa, mit einer aktuellen globalen Anbaukapazität von 247 metrischen Tonnen Cannabis. Phase II umfasst die Bepflanzung auf dem Außenstandort Cayuga in diesem Frühling. Die ersten Verkäufe aus den Ernten der Phase I werden Ende Q4 erwartet, während die Ernte der Phase II im Oktober 2025 beginnt.
Die Einrichtungen von Tilray umfassen Betriebe in Leamington, Nanaimo, Foss, Cayuga und Masson in Kanada sowie Einrichtungen in Cantanhede, Portugal, und Neumünster, Deutschland, die über 20 legale Cannabis-Märkte weltweit bedienen.
Positive
- Increased production capacity by 60 metric tonnes annually
- Total Canadian cannabis cultivation capacity expanded to 210 metric tonnes
- Global cultivation capacity reached 247 metric tonnes
- Presence in over 20 legal cannabis markets globally
- Strategic expansion aligned with growing market demand
Negative
- Revenue impact from expansion not immediate, with first Phase I sales expected late in Q4
- Previously idle capacity during COVID-19 indicates past operational challenges
Insights
Tilray’s significant expansion of production capacity marks a strategic pivot that could reshape its market position and financial performance. The addition of 60 metric tonnes of annual cultivation capacity represents a 40% increase in Canadian operations, bringing the total to 210 metric tonnes. This expansion carries several critical implications:
The timing of revenue impact is carefully structured: Phase I harvests will begin contributing to sales in late Q4, while Phase II’s outdoor cultivation will commence in October 2025. This staggered approach helps manage working capital and allows for market absorption of increased supply.
The reactivation of previously idle sections at Aphria One demonstrates improved capacity utilization and potential operating leverage benefits. By spreading fixed costs across higher production volumes, Tilray could see margin improvements, particularly important in the current competitive cannabis market.
The geographic diversification of facilities (8 locations across Canada and Europe) creates a robust supply chain network that can:
- Mitigate regional cultivation risks
- Optimize distribution costs to various markets
- Maintain GMP compliance for international medical markets
- Adapt to local market demands and regulations
The convertible facility in Masson, Quebec, currently growing cucumbers, provides valuable optionality for further expansion without requiring new capital investment. This flexibility in capacity management could prove important as market dynamics evolve.
With access to over 20 legal cannabis markets globally, this expanded capacity positions Tilray to capture market share in both established and emerging markets, particularly in Europe where medical cannabis adoption is growing. The increased scale could provide competitive advantages in procurement, production efficiency and market presence.
02/10/2025 – 07:00 AM
Tilray Increases Industry-Leading Capacity to Meet Global Demand, Driving Growth Across Canada and Europe
NEW YORK and LEAMINGTON, Ontario, Feb. 10, 2025 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, today announced the completion of Phase I of its accelerated growth plan for its cannabis supply chain, which began with increased planting in late 2024. Phase II of the growth plan includes planting the outdoor cultivation site in Cayuga this spring. Tilray’s primary Canadian production facilities, Aphria One and Aphria Diamond, are now fully planted and positioned to capture the growing demand from Canadian and International cannabis markets. Certain sections of Aphria One, which were previously idled during the COVID-19 pandemic, are now back online.
These sites are projected to produce an additional 60 metric tonnes of cannabis annually, increasing Tilray’s current Canadian cannabis cultivation capacity to 210 metric tonnes per year and supplying both Canadian and International markets, including Europe, to meet rising global demand. Tilray expects the first sales of the Phase I harvests to occur late in the second half of our fourth quarter and the Phase II harvest to begin in October 2025.
Tilray operates eight state-of-the-art cannabis cultivation and manufacturing facilities across Canada and Europe. In Canada, these include Aphria One and Aphria Diamond in Leamington, Ontario; Broken Coast in Nanaimo, British Columbia; Redecan in Foss, Ontario; an outdoor site in Cayuga, Ontario; and a Dutch-style greenhouse in Masson, Quebec, currently growing cucumbers but convertible for cannabis as needed. In Europe, Tilray Portugal, located in Cantanhede, serves as a research, processing, cultivation, packaging, and distribution facility primarily for the medical cannabis market in Europe. Additionally, Aphria RX in Neumünster, Germany, functions as a cultivation and processing facility supplying the German market. Tilray’s global cannabis cultivation capacity currently stands at approximately 247 metric tonnes, with the potential to expand further as demand increases.
As global demand for cannabis continues to rise, Tilray is strategically positioned to succeed. The Company’s extensive cultivation capacity is designed to provide a consistent and reliable supply of premium cannabis products to over 20 legal cannabis markets worldwide. Tilray’s commitment to excellence is evident through its GMP certifications, strict quality control processes, sustainable cultivation practices, and innovative product offerings that cater to a diverse consumer base.
About Tilray Brands
Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. Tilray’s mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy and create memorable experiences. Tilray’s unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.
For more information on how we are elevating lives through moments of connection, visit Tilray.com and follow @Tilray on all social platforms.
Forward-Looking Statements
Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations concerning, among other things, the Company’s ability to maximize its cannabis facility utilization rates at full capacity. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws.
For further information:
Media: news@tilray.com
Investor Relations: investors@tilray.com
FAQ
What is Tilray’s (TLRY) new annual cannabis production capacity after the Phase I expansion?
After Phase I expansion, Tilray’s Canadian cannabis cultivation capacity increased to 210 metric tonnes annually, with a global capacity of 247 metric tonnes.
When will Tilray (TLRY) begin sales from its Phase I expansion?
Tilray expects to begin first sales from Phase I harvests in the late second half of their fourth quarter.
How many cultivation facilities does Tilray (TLRY) operate globally?
Tilray operates eight state-of-the-art cannabis cultivation and manufacturing facilities across Canada and Europe.
What is the timeline for Tilray’s (TLRY) Phase II expansion in Cayuga?
Phase II includes planting at the outdoor Cayuga site in spring 2025, with harvest expected to begin in October 2025.
How much additional production capacity did Tilray (TLRY) gain from reactivating idle facilities?
The reactivation of previously idled sections added 60 metric tonnes to Tilray’s annual cannabis production capacity.
Search
RECENT PRESS RELEASES
Related Post
